Abstract Submission Guidance

The RPS Annual Conference 2023 offers an opportunity for pharmacy and pharmaceutical science professionals to showcase anything from small scale studies through to innovative original research. 

Please ensure that you read the following criteria carefully before submitting your work.

1. Abstract Submission Criteria

1.1 Authors

Lead author

Unless you inform us otherwise, it will be assumed that the lead author is also the presenting author. Ensure that your lead author’s email address is included. 

Please note that we can only accept one submission per presenting author. 

Co-authors

Add the names of co-authors on your study. The authors’ names should be added in the format:

[First name initial] [surname] (e.g., N. Patel). Please add any middle names as initials.

Author affiliations

Authors’ affiliations should be added to the submission template where indicated. Affiliation in this context is an author’s academic institution, company or place of work which is affiliated with this study.

Who is an author?

Authors of work presented at the RPS Annual Conference should identify with the ICMJE definition of authorship, which states that authorship credit should be based on:

  1. Substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data
  2. Drafting the submitted abstract (and presentation) or revising it critically for important intellectual content
  3. Approval of the version to be submitted/presented.

You can read further information at http://icmje.org/recommendations.

1.2 Title (max 20 words)

  • Ensure that your title is clear, concise and indicates what the research is about.
  • Avoid the use of acronyms

1.3 Keywords (max 5 words)

  • Enter up to five key words (not phrases) which summarise the basis of your research

1.4 Abstract body

Your abstract should follow a basic structure as outlined below:

  • Introduction
  • Aim
  • Methods (including an ethical approval statement)
  • Results
  • Discussion and Conclusion (including study limitations)
Bullet points are not permitted.

Your Methods section must include a statement confirming that your study has obtained ethical approval and by whom this was granted, or alternatively a statement confirming that ethical approval was not required and the reason for this.

1.5 Tables and Figures

No tables, figures or images are permitted.

1.6 References (max 3)

  • Include a maximum of three references at the end of your submission
  • Use the Vancouver referencing style for your references, with superscript for corresponding reference numbers
  • References should be numbered, listed in the order in which they occur and should include surname(s) and initials, article title, abbreviated name of the journal, journal year, volume number and first and last page numbers, for example:

Smith LP. Title of article, Abbreviated title of journal, Year; Volume (Issue): first page-last page

1.7 Word count

Your submission should be no longer than 500 words.

The word limit does not include your abstract title, headings, or references.

1.8 Number of copies

One copy of the abstract must be submitted in full and one anonymised.  

Please use the submission templates provided.  The anonymised version will require you to remove names, affiliations, or any other identifiers.

2. Submission and review

Submit your abstract using our online form.

We will not accept:

  • Abstracts which do not adhere to the guidance outlined above.
  • Abstracts which are incomplete (including those without references). 
  • More than one submission from each presenting author.
  • Abstracts submitted any time after the submission deadline.

I confirm I have...

☐ Read the abstract submission guidance
☐ Clearly outlined the aims and objectives of my research
☐ Included a statement confirming that my study has obtained ethics approval, or alternatively a statement confirming that ethical approval was not required and the reason for this
☐ Addressed the limitations of my research in the discussion/conclusion section
☐ Ensured that my abstract body contains no more than 500 words
☐ Included appropriate references
☐ Proofread my abstract for grammar or spelling mistakes
☐ Asked a supervisor or colleague to review my abstract and provide feedback
☐ Submitted my abstract using the template provided
☐ Selected the FIP Development Goals that my work is aligned to.

 

3. Next steps

Abstract submissions will be accepted on the basis that they are novel with aims, methods and results clearly outlined and conclusions supported by findings. 

Your work must have been subject to, and passed, an ethical review process (where relevant) in order to be accepted for presentation at the Conference.

Successful authors will be selected to either present a poster, or to take part in a 'lightening presentation' during the conference.  

We hope as many of you as possible are able to join us in-person in London.  The conference will have both in-person and virtual attendance options.

Lightening presentations and poster prizes will be for in-person attendees only.

Questions?

If you have any questions about the abstract submission process, please contact [email protected]